title: Role of palifermin in fluorouracil-based therapy for metastatic colorectal cancer.
authors.forename: John R
authors.initials: JR
authors.lastname: Zalcberg
authors.forename: Lee S
authors.initials: LS
authors.lastname: Rosen
authors.forename: Ehtesham
authors.initials: E
authors.lastname: Abdi
authors.forename: Ian D
authors.initials: ID
authors.lastname: Davis
authors.forename: John
authors.initials: J
authors.lastname: Gutheil
authors.forename: Frederick M
authors.initials: FM
authors.lastname: Schnell
authors.forename: Alessandra
authors.initials: A
authors.lastname: Cesano
authors.forename: Urte
authors.initials: U
authors.lastname: Gayko
authors.forename: Mon-Gy
authors.initials: MG
authors.lastname: Chen
authors.forename: Stephen
authors.initials: S
authors.lastname: Clarke
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000556:secondary; D051523:Fibroblast Growth Factor 7 / Q000627:therapeutic use*; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage; D009061:Mouth Mucosa / Q000187:drug effects*; D052016:Mucositis / Q000139:chemically induced / Q000188:drug therapy* / Q000517:prevention & control; D016896:Treatment Outcome
chemical_list: D051523:Fibroblast Growth Factor 7; D002955:Leucovorin; D005472:Fluorouracil